MeVis Medical Solutions AG (M3V.DE)
EUR 26.2
(0.0%)
EUR 26.2
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 6.44 Million EUR | -35.58% |
| 2022 | 7.88 Million EUR | 50.12% |
| 2021 | 5.24 Million EUR | -9.59% |
| 2020 | 5.8 Million EUR | -28.89% |
| 2019 | 8.16 Million EUR | 21.98% |
| 2018 | 6.69 Million EUR | -15.93% |
| 2017 | 7.96 Million EUR | 66.11% |
| 2016 | 4.79 Million EUR | 7.23% |
| 2015 | 4.47 Million EUR | 14.91% |
| 2014 | 3.89 Million EUR | -3.38% |
| 2013 | 4.02 Million EUR | 35.33% |
| 2012 | 2.97 Million EUR | 281.18% |
| 2011 | -1.64 Million EUR | 69.74% |
| 2010 | -5.42 Million EUR | -432.33% |
| 2009 | 1.63 Million EUR | 145.56% |
| 2008 | 665 Thousand EUR | 36.55% |
| 2007 | 487 Thousand EUR | -89.12% |
| 2006 | 4.47 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.59 Million EUR | 38.57% |
| 2024 Q1 | 1.15 Million EUR | -4.98% |
| 2023 Q1 | 1.21 Million EUR | -28.52% |
| 2023 FY | 5.07 Million EUR | -35.58% |
| 2023 Q4 | 1.21 Million EUR | 0.0% |
| 2023 Q3 | 1.21 Million EUR | -0.64% |
| 2023 Q2 | 1.21 Million EUR | 0.0% |
| 2022 Q3 | 1.7 Million EUR | -42.67% |
| 2022 FY | 7.88 Million EUR | 50.12% |
| 2022 Q4 | 1.7 Million EUR | 0.0% |
| 2022 Q1 | 1.52 Million EUR | -18.92% |
| 2022 Q2 | 2.97 Million EUR | 95.04% |
| 2021 Q1 | 1.22 Million EUR | -56.25% |
| 2021 FY | 5.24 Million EUR | -9.59% |
| 2021 Q4 | 1.88 Million EUR | 46.28% |
| 2021 Q3 | 1.28 Million EUR | -58.52% |
| 2021 Q2 | 3.1 Million EUR | 154.05% |
| 2020 FY | 5.8 Million EUR | -28.89% |
| 2020 Q1 | 1.47 Million EUR | -46.98% |
| 2020 Q2 | 2.86 Million EUR | 93.44% |
| 2020 Q3 | 1.3 Million EUR | -54.48% |
| 2020 Q4 | 2.79 Million EUR | 114.34% |
| 2019 Q4 | 2.78 Million EUR | 61.33% |
| 2019 FY | 8.16 Million EUR | 21.98% |
| 2019 Q3 | 1.72 Million EUR | 3.97% |
| 2019 Q2 | 1.66 Million EUR | -16.18% |
| 2019 Q1 | 1.98 Million EUR | -11.98% |
| 2018 Q3 | 1.3 Million EUR | 10.32% |
| 2018 Q2 | 1.18 Million EUR | -39.51% |
| 2018 Q1 | 1.95 Million EUR | -25.84% |
| 2018 FY | 6.69 Million EUR | -15.93% |
| 2018 Q4 | 2.25 Million EUR | 72.85% |
| 2017 Q1 | 2.87 Million EUR | 49.27% |
| 2017 Q3 | 1.71 Million EUR | 133.61% |
| 2017 Q4 | 2.63 Million EUR | 53.47% |
| 2017 Q2 | 735 Thousand EUR | -74.43% |
| 2017 FY | 7.96 Million EUR | 66.11% |
| 2016 Q4 | 1.92 Million EUR | 73.51% |
| 2016 Q1 | 850 Thousand EUR | -57.35% |
| 2016 FY | 4.79 Million EUR | 7.23% |
| 2016 Q3 | 1.11 Million EUR | -6.17% |
| 2016 Q2 | 1.18 Million EUR | 39.18% |
| 2015 FY | 4.47 Million EUR | 14.91% |
| 2015 Q4 | 1.99 Million EUR | 83.69% |
| 2015 Q3 | 1.08 Million EUR | 100.18% |
| 2015 Q2 | 542 Thousand EUR | -26.76% |
| 2015 Q1 | 740 Thousand EUR | -45.63% |
| 2014 Q4 | 1.36 Million EUR | 24.29% |
| 2014 Q3 | 1.09 Million EUR | 57.78% |
| 2014 Q2 | 694 Thousand EUR | -19.68% |
| 2014 Q1 | 864 Thousand EUR | -43.31% |
| 2014 FY | 3.89 Million EUR | -3.38% |
| 2013 Q2 | 806 Thousand EUR | -21.29% |
| 2013 Q1 | 1.02 Million EUR | 47.34% |
| 2013 FY | 4.02 Million EUR | 35.33% |
| 2013 Q3 | 832 Thousand EUR | 3.23% |
| 2013 Q4 | 1.52 Million EUR | 83.17% |
| 2012 Q3 | 634 Thousand EUR | 1.93% |
| 2012 Q4 | 695 Thousand EUR | 9.62% |
| 2012 Q2 | 622 Thousand EUR | 126.97% |
| 2012 FY | 2.97 Million EUR | 281.18% |
| 2012 Q1 | -2.3 Million EUR | -577.43% |
| 2011 Q3 | -327 Thousand EUR | -164.24% |
| 2011 Q1 | -6.26 Million EUR | -1016.69% |
| 2011 FY | -1.64 Million EUR | 69.74% |
| 2011 Q2 | 509 Thousand EUR | 108.13% |
| 2011 Q4 | 483 Thousand EUR | 247.71% |
| 2010 Q1 | 920 Thousand EUR | 280.17% |
| 2010 Q2 | 149 Thousand EUR | -83.8% |
| 2010 Q3 | 1000.00 EUR | -99.33% |
| 2010 FY | -5.42 Million EUR | -432.33% |
| 2010 Q4 | 683 Thousand EUR | 68200.0% |
| 2009 Q4 | 242 Thousand EUR | 611.76% |
| 2009 Q2 | 437 Thousand EUR | 0.0% |
| 2009 FY | 1.63 Million EUR | 145.56% |
| 2009 Q3 | 34 Thousand EUR | -92.22% |
| 2008 Q3 | 558 Thousand EUR | 0.0% |
| 2008 FY | 665 Thousand EUR | 36.55% |
| 2007 FY | 487 Thousand EUR | -89.12% |
| 2006 FY | 4.47 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DocCheck AG | 3.54 Million EUR | -81.897% |
| CompuGroup Medical SE & Co. KGaA | 155.16 Million EUR | 95.847% |
| Nexus AG | 24.76 Million EUR | 73.981% |